About
Basic Data Updated:
7 days agoPanacea Biotec Limited is a biotechnology company that is involved in various aspects of the pharmaceutical industry, including research and development, manufacturing, sales, distribution, and marketing. The company's focus is on the production of pharmaceuticals, vaccines, and biosimilars. These products are manufactured at the company's production facilities located in Baddi (Himachal Pradesh), Lalru (Punjab), and Delhi. These facilities are equipped to produce a wide range of products, such as tablets, capsules (including soft gelatin), ointments (including transgel formulation), liquids, and herbal formulations.
Industry
Company Details
- Location
Mohali, Punjab, India
- Website1222442
- Telephone1222442
- Email Address1222442
CIN/LLPIN/FCRN | L33117PB1984PLC022350 |
Company No. | 022350 |
Stock Symbol | BSE : 531349 NSE : PANACEABIO |
Company Classification | Public Limited Indian Non-Government Company |
Incorporation Date | 02 Feb 1984 |
Date of AGM | 29 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Listed |
ROC Code | Roc Chandigarh |
Products or Services related to Panacea Biotec Limited
Financials of Panacea Biotec Limited
Enhance accessibility to Panacea Biotec's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Panacea Biotec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Panacea Biotec Limited
Unlock and access historical data on people associated with Panacea Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
- Vinod Goel Company Secretary
Appointment Date: 13-Jan-1999
Status: Current
SJ
Sandeep Jain Managing DirectorAppointment Date: 15-Nov-1984
Status: Current
RJ
Rajesh Jain Managing DirectorAppointment Date: 25-Nov-2006
Status: Current
DG
Devender Gupta CFOAppointment Date: 29-May-2015
Status: Current
Board Members(9)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Axis Bank Limited Creation Date: 05 Jan 2022 | ₹2.96 M | Satisfied |
Others Creation Date: 04 Feb 2020 | ₹754.44 Cr | Satisfied |
Others Creation Date: 06 Apr 2019 | ₹739.69 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panacea Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Recent activity within the organization
Charges
A charge registered on 05 Jan 2022 via Charge ID 100566669 with Axis Bank Limited was fully satisfied on 18 Mar 2024.
18 Mar 2024Director Appointment
Ambika Sharma was appointed as a Additional Director was appointed as a Additional Director on 12 Mar 2024 & has been associated with this company since 1 month 16 days .
12 Mar 2024Annual General Meeting
Panacea Biotec Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Panacea Biotec Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
31 Mar 2023Director Appointment
Narotam Kumar Juneja was appointed as a Director was appointed as a Director on 01 Apr 2022 & has been associated with this company since 2 years 28 days .
01 Apr 2022
Recent News, Updates & Announcement
- Panacea Biotec introduces generic version of cancer drug in Canada.
The Hindu 28 Oct 2023
- Panacea Biotec partners with Serum Institute of India.
Six in one has the potential of over 250 million doses in next 34 years with a market size of over 125 Billion annually.
ETHealthWorld 18 Jan 2018
- Panacea Biotec gets USFDAs nod for its generic breast cancer drug.
Biovoicenews 01 Dec 2017
- Panacea Biotec gets USFDA nod to launch Prasugrel tablets.
The companys firsttofile abbreviated new drug application ANDA of Prasugrel 5 mg and 10 mg tablets has been approved by the US Food and Drug Administration USFDA Panacea Biotec said in a BSE filing.
PTI 24 Oct 2017
- Panacea Biotec receives manufacturing authorization for 22 medicinal products.
Mumbai Panacea Biotec said that it has received the Certificate of GMP compliance from State Service of Ukraine on Medicines and Drugs Control with Manufacturing Authorization for 22 medicinal .
Business Medical Dialogues 18 Oct 2017
Frequently asked questions
What is the Incorporation or founding date of Panacea Biotec Limited?